HS Code for GLP-1: 2937.19

PRODUCT: GLP-1 drugs, or glucagon-like peptide-1 receptor agonists, are a class of medications primarily used to manage type 2 diabetes and, more recently, obesity. These drugs mimic the action of the naturally occurring hormone GLP-1, which plays a crucial role in regulating blood sugar levels by enhancing insulin secretion, inhibiting glucagon release, and slowing gastric emptying. Key components of GLP-1 drugs include synthetic peptides that bind to GLP-1 receptors in the pancreas and other tissues. Common materials used in their formulation may include stabilizers and preservatives to ensure efficacy and shelf-life. These medications are typically administered via subcutaneous injection and may come in pre-filled pens or vials. GLP-1 drugs not only help improve glycemic control but also promote weight loss, making them valuable for individuals dealing with both diabetes and obesity. Regular monitoring of blood sugar levels and adherence to a comprehensive treatment plan, including diet and exercise, are essential for optimal results.

REASONING: The product description clearly identifies GLP-1 drugs as synthetic peptides that act as hormones, specifically designed for managing diabetes and obesity. The most relevant HS code from the provided nomenclature is '293719', which covers polypeptide hormones and their analogues, used primarily as hormones. This code is supported by previous classification opinions, particularly the one regarding Liraglutide, a GLP-1 analog, which was classified under the same HS code. The high evaluation score of 0.930766821 for this classification further reinforces its relevance.

CONCLUSION: [293719]